[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100654062":3},{"organization":4,"outcomesModule":7,"designInfo":39,"detailedDescription":38,"studyPopulation":38,"armGroups":48,"interventions":59,"overallOfficials":38,"centralContacts":38,"locations":38,"responsibleParty":65,"collaborators":38,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":38,"enrollmentInfo":79,"targetDuration":38,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":89,"overallStatus":94,"whyStopped":38,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":38},{"fullName":5,"class":6},"Fu Jen Catholic University Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":16,"otherOutcomes":38},[9,13],{"measure":10,"description":11,"timeFrame":12},"Diabetes management self-efficacy","1. The Chinese version of the Diabetes Management Self-Efficacy Scale(C-DMSES) includes 20 items across four subscales:\n\n   1. Nutrition: 9 items\n   2. Physical activity and weight control: 4 items\n   3. Medication treatment: 3 items\n   4. Blood glucose and foot care: 4 items\n2. Scores range from 0 to 10.\n3. The scale has good reliability, with an overall Cronbach's α of .93.\n4. Subscale Cronbach's α values range from .77 to .93.\n5. The scale also has good test-retest reliability, with Pearson's r = .86, p \\\u003C .01.","Baseline, 3 months, and 6 months.",{"measure":14,"description":15,"timeFrame":12},"Diabetes self-management obstacles","Diabetes self-management obstacles will be measured using the Chinese Version of the Diabetes Obstacles Questionnaire-Short Form (CDOQ-S). Each item is rated on a 5-point Likert scale, ranging from 1 to 5. The items are negatively scored, and higher scores indicate greater obstacles in diabetes self-management.",[17,21,25,29,32,35],{"measure":18,"description":19,"timeFrame":20},"HbA1c","Glycated hemoglobin (HbA1c) will be measured using laboratory blood tests and reported as a percentage (%)","Baseline, 3 months, and 6 months",{"measure":22,"description":23,"timeFrame":24},"Fasting plasma glucose","Fasting plasma glucose will be measured using laboratory blood tests and reported in milligrams per deciliter (mg\u002FdL).","Baseline, 3months, and 6months",{"measure":26,"description":27,"timeFrame":28},"Triglycerides","Serum triglyceride levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg\u002FdL).","Baseline, 3months, and 6 months",{"measure":30,"description":31,"timeFrame":12},"Total cholesterol","Serum total cholesterol levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg\u002FdL).",{"measure":33,"description":34,"timeFrame":12},"LDL","Serum low-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg\u002FdL).",{"measure":36,"description":37,"timeFrame":12},"HDL","Serum high-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg\u002FdL).",null,{"allocation":40,"interventionModel":41,"interventionModelDescription":42,"primaryPurpose":43,"observationalModel":38,"timePerspective":38,"maskingInfo":44},"RANDOMIZED","PARALLEL","This is a two-arm, parallel-group randomized controlled trial. Participants will be assigned to either the control group or the intervention group. Both groups will use a diabetes self-management mobile application. The intervention group will receive additional video-based health education and multidisciplinary team care through the application.","HEALTH_SERVICES_RESEARCH",{"masking":45,"maskingDescription":38,"whoMasked":46},"SINGLE",[47],"OUTCOMES_ASSESSOR",[49,53],{"label":50,"type":51,"description":52,"interventionNames":38},"Basic self-management mobile application use.","NO_INTERVENTION","Participants in the control group will receive routine diabetes care and use the basic functions of the diabetes self-management mobile application. The basic app functions include self-recording of blood glucose, medication, diet, physical activity, and related health information. Participants in this group will not receive additional video-based health education or multidisciplinary team care through the application.",{"label":54,"type":55,"description":56,"interventionNames":57},"Enhanced diabetes self-management mobile application use.","EXPERIMENTAL","Participants in the intervention group will receive routine diabetes care and access to an enhanced diabetes self-management mobile application, which includes basic self-management recording functions, video-based health education, and multidisciplinary team care to support diabetes self-management.",[58],"Behavioral: Researcher-Designed Diabetes Self-Management Application",[60],{"type":61,"name":62,"description":63,"armGroupLabels":64,"otherNames":38},"BEHAVIORAL","Researcher-Designed Diabetes Self-Management Application","Participants in the intervention group will receive routine diabetes care and use the enhanced diabetes self-management mobile application. In addition to the basic self-management recording functions, the intervention group will receive video-based health education and multidisciplinary team care through the application. The multidisciplinary team may include healthcare professionals such as physicians, nurses, dietitians, and pharmacists, who provide diabetes-related guidance to support daily self-management, self-efficacy, and metabolic control.",[54],{"type":66,"investigatorFullName":67,"investigatorTitle":68,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"PRINCIPAL_INVESTIGATOR","SZU-YI WANG","Principal Investigator","100654062","effects-of-a-researcher-designed-diabetes-self-management-app-on-self-management-obstacles-self-efficacy-and-physiological-indicators-in-type-2-diabetes-100654062",false,"NCT07794384","Effects of a Researcher-Designed Diabetes Self-Management App on Self-Management Obstacles, Self-Efficacy, and Physiological Indicators in Type 2 Diabetes","Construction and Evaluation of a Self-management APP for Effectiveness in Self-Management, Self-Efficacy, and Metabolic Indicators of Patients With Type 2 Diabetes.","Application","Inclusion Criteria:\n\n* Diagnosed with type 2 diabetes for more than 6 months and Hemoglobin A1c (HbA1c) \\> 7.5%.\n* Having diabetes self-management obstacles.\n* Aged 18 years or older.\n* Conscious and able to communicate.\n* Having a smartphone with internet access.\n* Willing to participate in the study and provide written informed consent.\n\nExclusion Criteria:\n\n* Gestational diabetes mellitus.\n* Currently taking steroid medications.\n* Having a severe infection requiring hospitalization within the past 6 months.\n* Unable to perform self-care independently.\n* Having participated in or currently participating in an educational program of a similar nature.","ALL","18 Years",{"count":80,"type":81},80,"ESTIMATED","INTERVENTIONAL",[84],"NA","This study aims to evaluate the effectiveness of a self-developed diabetes self-management mobile application on disease self-management outcomes among individuals with type 2 diabetes.",[87,88],"Type 2 Diabetes Mellitus (T2DM)","Self-management",[90,91,92,93],"Diabetes self-management","Diabetes Obstacles","Self-efficacy","Metabolic indicators","NOT_YET_RECRUITING","2026-08-28",{"date":97,"type":98},"2026-08-31","ACTUAL",{"date":100,"type":81},"2026-09-01",{"date":102,"type":81},"2028-07-31",{"name":5,"class":6}]